A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

Geneticists have adapted CRISPR technology to correct Duchenne muscular dystrophy mutations (DMD).

Among the latest examples, a UT Southwestern study of retired NFL players published this spring showed no significant association between the length of their careers, the number of concussions they sustained, and their cognitive function later in life. Other research has found comparable results in

Mrs. Hann’s optimism stems from advancements being made by a gene therapy program at UT Southwestern Medical Center where leading experts are engineering innovative treatments for some of the world’s rarest neurological diseases.

Researchers are publishing heart-related space research that helps us to understand the problem of low blood pressure.

Drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating ovarian and prostate cancers.

Aggressive methods for reducing high blood sugar following a severe stroke are not more effective than standard, lower risk treatments, according to a new study that offers clarity to a long-debated issue in stroke care.

The COVID-19 pandemic has led to new rules and expectations for clinical trials.

The molecular changes that lead to Fuchs’ endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients.

A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse.